A new synthesis of 2-oxa-7-azaspiro[3.5]nonane is described. Spirocyclic oxetanes, including 2-oxa-6-azaspiro[3.3]heptane were converted into o-cycloalkylaminoacetanilides for oxidative cyclizations using Oxone ® in formic acid. The expanded spirocyclic oxetane successfully gave the [1,2-a] ring-fused benzimidazole. X-ray crystal structure of the resultant new tetracyclic system, 1ʹ,2ʹ-dihydro-4ʹH-spiro[oxetane-3,3ʹ-pyrido[1,2-a]benzimidazole] and the azetidine ring-opened adduct, N- (2-acetamido-4-bromophenyl)-N-{[3-(chloromethyl) oxetan-3-yl]methyl}acetamide are disclosed.
Introduction
Oxetane is considered as a polar equivalent of the gem-dimethyl group (Figure 1 ) [1] [2] [3] . Spirocyclic oxetanes such as 2-oxa-6-azaspiro [3.3] heptane (1a) and 2-oxa-7-azaspiro [3.5] nonane (1b) were proposed as valuable structural alternatives to ubiquitous morpholine in medicinal chemistry [4] . A drug discovery project within our group demanded a substituent that enabled higher binding affinities to the NAD(P)H:quinone oxidoreductase 1 (NQO1) active site [5] . NQO1 is an enzyme over-expressed in cancer cell lines. Our attention turned to oxetane due to its heralded metabolic robustness in comparison to carbonyl alternatives, while offering the hydrogen bonding capacity necessary for efficient binding to the His194 residue of NQO1 enabling more efficient reduction of benzimidazolequinone and imidazobenzimidazolequinone substrates. The following article describes 
Results and Discussion

Synthesis of Spirocyclic Oxetanes
The synthesis of the oxalate salt of 2-oxa-6-azaspiro [3.3] heptane 1a starting from the condensation of 3-bromo-2,2-bis(bromomethyl)propan-1-ol with p-tosylamide has been described [4] . The expanded analogue 1b is commercially available but expensive, and a new synthetic pathway is now reported (Scheme 1). N-tosyl-piperidine-4,4-diethyl ester 3 was prepared using the reaction of diethyl malonate with N-tosylbis(2-bromoethyl)amine, and similar transformations are available in patents [6, 7] . Lithium aluminum hydride reduction provides diol 4, which is subjected to a one-pot mesylation and ring closure to give the previously unreported oxetane 5. The tosyl group was removed and the oxalate salt of 2-oxa-7-azaspiro[3.5]nonane 1b formed. An alternative synthesis appears in a patent via the ring-closure of 2,2′-(oxetane-3,3-diyl)bis(ethan-1-ol) to give 1b [8] . The latter multi-step synthesis begins with a Wittig reaction on 3-oxetanone, and represents a longer more costly preparation of 1b. Scheme 1. Synthesis of the oxalate salt of 2-oxa-7-azaspiro [3.5] nonane (1b).
Synthesis of o-Cycloalkylaminoacetanilides
Nucleophilic aromatic substitution onto 1,4-dibromo-2-nitrobenzene using the oxalate salts of spirocyclic oxetanes 1a and 1b was possible in yields of >90% when using a large excess of potassium carbonate in DMF (Schemes 2 and 3). Reduction of the nitro group of 6a and 6b using iron and aqueous ammonium chloride yielded the corresponding anilines 7a and 7b in 95% yield. The acetylation was optimized with aniline 7a, where the initial attempt using acetyl chloride gave the desired acetamide 8a in 64% yield together with adduct 9a of ring-opening of the azetidine in 19% yield (Scheme 2). By-product 9a was confirmed by X-ray crystallography ( Figure 2 ). As pointed out by the Reviewer this may have occurred using the chloride ion liberated from the first acetylation. The ring-opening of azetidines by the nucleophilic attack of halide ions on azetidinium ions has been previously described [9] . Acetylations using acetic anhydride were in contrast regioselective giving diacetylated adduct 10a in 90% yield with neat acetic anhydride, while acetylation with acetic anhydride in methanol gave the desired product 8a in 81% yield. The latter conditions gave the analogous acetamide of 2-oxa-7-azaspiro [3.5] 
Fusion of the Spirocyclic Oxetanes
In order to fuse the spirocyclic oxetane of 8a and 8b, the well-established oxidative cyclization reaction of acetamide onto the neighbouring cyclic amine was used [11] [12] [13] . Oxone ® in formic acid is as an expedient means of converting o-cycloalkylaminoacetanilides into [1,2-a] alicyclic ring-fused benzimidazoles and double annulated imidazobenzimidazoles in high yields [13] . Using the latter conditions (Scheme 4), acetanilide 8a gave a mixture of products indicating degradation of the spirocyclic oxetane and an absence of the desired benzimidazole 2a. In contrast the 2-oxa-7-azaspiro[3.5]nonane fused benzimidazole 2b was isolated in 74% yield at the end of the reaction of 8b without the requirement for chromatography by simple organic extraction from the basified aqueous mixture. The structure of the novel tetracyclic system 2b was confirmed by X-ray crystallography ( Figure 3 ). 
Experimental Section
General
All chemicals were obtained from commercial sources and used without further purification. Thin layer chromatography (TLC) was performed on TLC silica gel 60 F254 plates. Dry vacuum column chromatography was carried out on silica gel (Apollo Scientific ZEOprep 60/15-35 microns). Melting points were measured on a Stuart Scientific melting point apparatus SMP1. Infrared spectra were recorded using a Perkin-Elmer Spec 1 with ATR attached. 1 H-NMR spectra were recorded using a Joel ECX 400 MHz instrument equipped with a DEC AXP 300 computer workstation. The chemical shifts were recorded in ppm relative to tetramethylsilane. 13 C-NMR data were collected at 100 MHz with complete proton decoupling. High resolution mass spectra (HRMS) were carried out using ESI time-of-flight mass spectrometer (TOFMS). The precision of all accurate mass measurements were better than 5 ppm. NMR spectra of all compounds are available in the Supplementary Materials document accompanying this article.
Experimental Procedures
Synthesis of Spirocyclic Oxetanes
Bis (2-oxa-6-azaspiro [3.3] heptan-6-ium) ethanedioate (oxalate salt of 1a) was prepared according to the literature [4] .
Diethyl 1-(4-methylbenzene-1-sulfonyl)piperidine-4,4-dicarboxylate (3)
. Diethyl malonate (0.500 g, 3.1 mmol) and NaH (0.165 g, 6.9 mmol) in DMF (50 mL) were heated at 80 °C for 30 min. N,N-bis(2-bromoethyl)-4-methyl-1-sulfonamide [14] (1.320 g, 3.4 mmol) was added and heating at 80 °C continued for 12 h. The cooled mixture was evaporated, EtOAc (50 mL) added, and washed with aqueous LiCl (5%) solution (3 × 50 mL). The organic extracts were dried (Na2SO4) and evaporated to dryness, and the residue purified by column chromatography using gradient elution of petroleum ether/EtOAc to yield the title compound (0.987 g, 83%) as a white solid; Rf 0.32 (1:4 EtOAc/Pet); mp 90-92 °C; νmax (neat, cm (5) . Methanesulfonyl chloride (0.4 mL, 5.2 mmol) in THF (5 mL) was added to diol 4 (1.700 g, 5.7 mmol) in THF (50 mL) via syringe pump at a rate of 1.7 mL/h, while potassium tert-butoxide (0.636 g, 5.7 mmol) was added in portions (one third per h). The mixture was stirred at room temperature for 1 h with further potassium tert-butoxide (1.900 g, 17.0 mmol) added, and stirred for 2 h. The mixture was evaporated, EtOAc (50 mL) added, washed with water (2 × 20 mL), and dried (Na2SO4). The solution was evaporated to dryness and the residue purified by column chromatography using gradient elution of petroleum ether/EtOAc to yield the title compound (1.160 g, 73%) as a white solid; Rf 0.44 (1:1 EtOAc/Pet); mp 168-172 °C; νmax (neat, cm Bis (2-oxa-7-azaspiro [3.5] nonan-7-ium) ethanedioate (oxalate salt of 1b). 2-Oxa-7azaspiro[3.5]nonane 5 (1.300 g, 4.6 mmol) and Mg turnings (0.780 g, 32.3 mmol) in MeOH (50 mL) were sonicated for 1 h. The mixture was evaporated to give a viscous grey residue to which Et2O (50 mL) and Na2SO4⋅10H2O (2.000 g) were added. After 30 min of stirring, the mixture was filtered, and anhydrous oxalic acid (0.210 g, 2.3 mmol) added to the filtrate to form a precipitate. The precipitate was collected and dried under vacuum to yield the title compound (0.580 g, 73%) as a white solid; mp 148-152 °C; νmax (neat, cm 
7-(4-Methylbenzene-1-sulfonyl)-2-oxa-7-azaspiro[3.5]nonane
Synthesis of Acetanilide Cyclization Precursors
General Procedure for the Synthesis of Nitrobenzenes 6a and 6b 1,4-Dibromo-2-nitrobenzene (1.000 g, 3.6 mmol), K2CO3 (9.820 g, 71.2 mmol) and spirocyclic oxetane 1a-1b oxalate salts (3.6 mmol) were heated in DMF (50 mL) at 80 °C for 4 h. The cooled mixture was evaporated, EtOAc (50 mL) added, and washed with aqueous LiCl (5%) solution (3 × 20 mL). The organic extracts were dried (Na2SO4), evaporated to dryness, and purified by column chromatography using gradient elution of petroleum ether/EtOAc to yield: [3.3] 
General Procedure for the Synthesis of Anilines 7a and 7b
Nitrobenzene 6a or 6b (2.00 mmol), Fe powder (0.370 g, 6.6 mmol), NH4Cl (59 mg, 1.0 mmol) and water (1.5 mL) in EtOH (5 mL) were heated at 80 °C for 5 h. EtOAc (50 mL) was added to the cooled mixture, which was filtered, washed with water (50 mL), and dried to yield: [3.3] heptan-6-yl)aniline (7a). (0.508 g, 95%) as a brown oil; νmax (neat, cm AcCl (0.2 mL, 2.5 mmol) was added over 5 min to aniline 7a (0.420 g, 1.6 mmol) and Et3N (0.4 mL, 2.7 mmol) in CH2Cl2 (10 mL) at 0 °C, and stirred for 3 h at room temperature. The solution was evaporated, EtOAc (50 mL) added, and washed with water (50 mL). The organic extracts were dried (Na2SO4), evaporated, and purified by column chromatography using gradient elution of petroleum ether/EtOAc to yield: [3.3] heptan-6-yl)phenyl]acetamide (10a). Aniline 7a (0.850 g, 3.2 mmol) in Ac2O (30 mL) was heated at 100 °C for 2 h. The cooled solution was evaporated, ice-water (50 mL) added, and stirred for 3 h. The resultant precipitate was purified by column chromatography using gradient elution of petroleum ether/EtOAc to yield the title compound (1.020 g, 90%) as a white solid; Rf 0.34 (1:1 EtOAc/Pet); mp 152-156 °C; νmax (neat, cm 
5-Bromo-2-(2-oxa-6-azaspiro
5-Bromo-2-(2-oxa-7-azaspiro[3.5]nonan-7-yl)aniline (7b
N-(2-acetylamido-4-bromophenyl)-N-{[3-(chloromethyl)oxetan-3-yl]methyl}acetamide (9a
N-Acetyl-N-[5-bromo-2-(2-oxa-6-azaspiro
